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Case Report

Anesthetic Considerations in a Patient With LVAD and
COVID-19 Undergoing Video-Assisted Thoracic
Surgery
1

Rutuja R. Sikachi, MD , Diana Anca, MD
Department of Anesthesiology, Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, NY

Increased survival with left ventricular assist devices (LVAD) has led to a large number of patients with LVADs presenting for noncardiac surgeries (NCS). With studies showing that a trained noncardiac anesthesiologist can safely manage these patients when they present for NCS, it is
vital that all anesthesiologists understand the LVAD physiology and its implications in various surgeries. This is even more relevant during the
current pandemic in which these complex cardiopulmonary interactions may be even more challenging in patients with coronavirus disease 2019
(COVID-19). The authors describe a case of a patient with COVID-19 with an LVAD who needed thoracoscopic decortication for recurrent complex pleural effusion and briefly discuss unique challenges presented and their management.
Ó 2021 Published by Elsevier Inc.
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INCREASED SURVIVAL with left ventricular assist devices (LVAD) has led to a large number of patients with LVADs
presenting for noncardiac surgeries (NCS).1,2 These NCS may
be needed for managing complications arising from LVAD or
otherwise. With studies showing that a trained noncardiac
anesthesiologist can safely manage these patients when they
present for NCS, it is vital that all anesthesiologists understand
the LVAD physiology and its implications in various surgeries.3-5 This is even more relevant during the current pandemic
in which these complex cardiopulmonary interactions may be
even more challenging in patients with coronavirus disease
2019 (COVID-19). Patients with an LVAD may present for
minor procedures, such as endoscopies or major surgeries
including general, vascular, or thoracic surgeries.6 They may
undergo monitored anesthesia care or general anesthesia with
various monitoring modalities ranging from noninvasive to
invasive depending on the clinical situation and stability of the
patient.7 The authors describe a case of a patient with COVID19 with an LVAD who needed thoracoscopic decortication for
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recurrent complex pleural effusion. They briefly discuss
unique challenges presented and their management in this
report.
Case Report
A 51-year-old woman with a HeartMate 3 (Abbott, Chicago,
IL) and who was hemodialysis- dependent was hospitalized for
a COVID-19 infection (height: 158 cm; weight: 59 kg; BMI:
23.6 kg/m2). She was transitioned from ECMO to LVAD as
destination therapy six months prior for stage D congestive
heart failure from lymphocytic myocarditis. During her previous year-long hospital stay, she had undergone multiple procedures. This included an indwelling tracheostomy that recently
was decannulated. During the stay, her chronic left-sided pleural effusion was found on CT scans to be increased and loculated, not amenable to drainage with a simple indwelling
pleural catheter. Hence, she was scheduled to undergo leftsided video-assisted thoracic surgery for decortication (Fig 1).
During preoperative evaluation, the LVAD was found to be
adequately functional, with a speed of 5,600 revolutions per
minute, flow of 3.5 L/min, power of 4.1 watts, and pulsatility
index of 1.9, with a mean arterial pressure of 90 mmHg.
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Fig 1. Computed tomography of the chest with axial cuts demonstrating a complex left pleural effusion with a component of hydropneumothorax. (A) Arrow demonstrating thickened left pleura. (B) Arrow demonstrating loculated pocket of air anteriorly with fluid posteriorly (hydropneumothorax). (C) Arrow demonstrating
complex left pleural space with atelectatic lung, loculated pleural effusion, and thickened pleura. (D) Arrow demonstrating loculated pleural effusion.

Preoperative oxygenation was stable on room air. Transthoracic echocardiogram showed severe global left and right ventricular systolic dysfunction but no pericardial effusion, septal
defects, or cardiac thrombi. From physical examination and
previous anesthesia records, she was found to have limited
mouth opening, Mallampati grade 3 airway. Mask ventilation
easily was achieved, but intubations were performed with a
video laryngoscope (GlideScope, Verathon, Bothell, WA)
with moderate difficulty in the past. The respiratory examination showed decreased air entry on the left side with no wheezing or stridor. Her anticoagulation with warfarin was bridged
with heparin infusion for the surgery and was stopped on the
morning of the surgery. Preoperative coagulation profile was
found to be normal. A preoperative fiberoptic evaluation was
not performed due to absence of any radiologic signs of stenosis on the CT scan and based on the authors’ discussions with
the thoracic surgery team.
In the operating room, a routine five-lead ECG was applied
to the chest and a pulse oximeter and NIBP cuff were applied
to the right arm. A defibrillator was available on standby. A
preinduction arterial line was inserted in the left brachial artery
under ultrasound guidance. A peripherally inserted central
venous catheter already was present and was used for intravenous medications. General anesthesia was induced after lowflow preoxygenation with intravenous etomidate 16 mg, 50 mg
of fentanyl, and succinylcholine 100 mg. The airway was
secured, once the patient became completely apneic, with an
8.0-mm standard cuffed endotracheal tube under video laryngoscopy visualization. Adequate PPE was used during the

entire procedure. An endobronchial blocker (Uniblocker, Fuji,
9 Fr) was inserted and secured in the left mainstem bronchus
under fiberoptic bronchoscopic (FOB) guidance. The patient
was positioned in the right lateral position to facilitate surgery,
and the position of the endobronchial blocker was confirmed
with FOB once again. The patient was ventilated only after
confirming a closed system throughout these maneuvers given
the positive COVID-19 status. Anesthesia was maintained
with intravenous fentanyl, sevoflurane/oxygen, and cisatracurium. The LVAD parameters did not change after initiating
one-lung ventilation. The arterial blood gas analysis once onelung ventilation was established demonstrated a pH of 7.27
with PCO2 of 55 and PO2 of 339. Ventilation was adjusted
to maintain normocarbia and was monitored throughout the
procedure using end-tidal CO2 and frequent ABGs. The pH
and PCO2 showed improvement once ventilation was
adjusted and adequate oxygenation was maintained. MAP
was maintained at about 80-to-90 mmHg throughout, close
to the patient’s baseline, with balanced anesthesia using
sevoflurane, fentanyl, and cisatracurium. Administration of
a vasopressor was not necessary. A transesophageal echocardiogram (TEE) was on standby in case further invasive
monitoring was required during the procedure. All the
involved personnel in the room wore appropriate personal
protective equipment during the surgery. The TEE cart was
covered with a plastic cover. Only required personnel,
instruments, and medications were kept in the room, with
one circulating nurse right outside the room to help with
additional supplies if required.
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At the end of the surgery, an intercostal block was performed with liposomal suspension of 1.3% bupivacaine, as
postoperative opioid patient-controlled analgesia was rendered
inappropriate for this patient. The bronchial blocker was
removed and two-lung ventilation was established. The patient
was extubated after reversal with neostigmine and glycopyrrolate and meeting all the extubation criteria. She was transferred
to the intensive care unit (ICU) awake and alert with supplemental oxygen and was restarted on intravenous heparin infusion. The surgical pathology from the procedure demonstrated
an acute fibrinous pleuritis that was managed with antibiotics.
Discussion
Patients with LVADs often have reduced right ventricular
function, and it is imperative to avoid factors that worsen pulmonary vascular resistance during the anesthetic management.
Anesthetic management of these patients becomes even more
challenging during thoracoscopic procedures given the crossinteractions between the LVAD physiology and one-lung ventilation physiology. In addition, patients with COVID-19 often
present with pulmonary findings that can affect the pulmonary
vascular resistance secondary to hypoxemia and make the
management of these patients even more challenging. Another
additional anesthetic consideration in the management of such
a patient with COVID-19 undergoing one-lung ventilation is
to avoid exposure of healthcare personnel given its potential as
an aerosol-generating procedure.
In this patient, one-lung ventilation was achieved with a
bronchial blocker. The bronchial blocker can offer fewer
hemodynamic disturbances as compared with a double-lumen
tube.8 Known difficult airway, history of tracheal stoma or
constriction, and limited mouth opening are relative contraindications for use of a double-lumen tube and this patient had
all of them.9,10 The Uniblocker was selected based on the ease
of use and the preference of the attending anesthesiologist.
Also, during the COVID-19 pandemic, a survey conducted by
the European Association of Cardiothoracic Anesthesia
showed that a bronchial blocker was the preferred technique
for lung isolation in patients who were COVID-19-positive,
were already intubated, and had difficult airways.11 It also is
easy to maintain a closed circuit with a bronchial blocker, and
it can help minimize aerosolization and exposure of perioperative personnel to the virus.12 Other described techniques to
facilitate one-lung ventilation in a patient with suspected
or confirmed COVID-10 infection include a laparoscopy
smoke evacuation system with an attached filter connected
to the tracheal lumen of the double- lumen tube to prevent
aerosolization of the particles and exposure of healthcare
workers.13
While dealing with LVAD patients, the main focus is on
supporting the right ventricular function to maintain hemodynamic stability.7 LVAD function is preload-dependent and
afterload-sensitive.7 Physiologically, preload depends on
venous return, right ventricular function, and pulmonary vascular resistance, all of which can be adversely affected during
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thoracoscopic procedures. Venous return decreases with lateral
positioning as well as positive-pressure ventilation. With left
lateral positioning there also is a risk of kinking of the LVAD
drive-line. Pump flow should be closely monitored during
positioning, and preload and afterload should be adjusted as
needed. The right ventricle is often poorly functional in
patients with an LVAD due to global cardiomyopathy, as in
the authors’ patient. This is further worsened due to an
increase in pulmonary vascular resistance during one-lung
ventilation and hypercarbia. Ventilation should be adjusted so
as to avoid hypoxia, hypercarbia, and acidosis to avoid right
heart strain. This may necessitate switching to two-lung ventilation.
Similar to preload, afterload also needs close monitoring
and management. Afterload is increased with inadequate depth
of anesthesia and sympathetic stimulation from laryngoscopy.
This can reduce the pump flow and promote pump thrombosis.
On the other hand, vasodilation from anesthesia can reduce the
afterload, causing excessive offloading from the left ventricle.
This creates anatomic distortion of the right ventricle, leading
to a suck-down phenomenon. Invasive monitoring with a pulmonary artery catheter or TEE is very helpful in guiding afterload management with fluids, blood products, and vasoactive
drugs, as needed, and should be used if an LVAD patient is
unstable. If required, vasopressin can be a good vasopressor
choice for such procedures, as it has minimal effect on pulmonary vasculature.14 Although it is important to understand the
complex cardiopulmonary interactions in these patients, there
were no hemodynamic disturbances noted in this patient and
the use of a vasopressor was not necessary. Postoperatively,
these patients should be cared for in the ICU setting by personnel knowledgeable about LVADs. For pain management,
regional and nonopioid analgesia techniques should be preferred, as opioids can lead to hypoventilation causing hypoxia,
hypercarbia, and acidosis, which have caused fatalities.15 In
addition, it is important to optimally manage the anticoagulation status during surgical interventions in patients with an
LVAD. Although anticoagulation carries the risk of bleeding
during the procedure, being off anticoagulation for prolonged
periods can lead to pump thrombosis. A well-coordinated multidisciplinary approach is essential to minimize the time off
anticoagulation. For surgeries with a high risk of bleeding,
warfarin can be held and bridged with heparin infusion, which
can be stopped on the morning of the planned procedure. After
the procedure, warfarin may be resumed when the risk of
bleeding is acceptable. The patient can be bridged with
heparin while waiting for the international normalized ratio
to reach the target.7,16 The patient was bridged with heparin, which was stopped on the morning of the procedure,
and restarted once the patient postoperatively was stable.
The anesthetic challenges, as well as approach to a patient
with an LVAD undergoing one-lung ventilation, is
described in Table 1.
Thus, in summary, the authors describe the challenges of
dealing with patients with LVAD undergoing noncardiac surgeries, especially during the COVID-19 pandemic.
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Table 1
Summary of Anesthetic Challenges and Approach in Patient With LVAD
Undergoing One-Lung Ventilation
Multidisciplinary planning: Close communication between LVAD
management team, surgery, and cardiac anesthesia; discussion should
involve preoperative optimization, postoperative recovery, and care; intraand postoperative need for invasive monitoring, transfusion goals, adequacy
of vascular access, and central vascular access planning as patients may be
difficult to cannulate.
Anticoagulation: Considerable institutional variability; for nonemergent
procedures warfarin and anti-platelets may be continued if the risk of
bleeding is low; if need to be stopped, bridging with heparin or heparin
alternative should be considered; emergent cases may require reversal of
anticoagulation with fresh frozen plasma, prothrombin complex concentrate,
or vitamin K. Decisions pertaining to anticoagulation should be taken in a
multidisciplinary fashion and tailored to each case.
Monitoring: Monitoring the LVAD monitor (speed, power, flow, pulsatality
index [PI]), might require the LVAD team/nurse in the room; pulse oximetry
and NIBP may not be helpful, depending on the degree of pulsatility;
cerebral oximetry could be an adjuvant to pulse oximetry and gauge of CO;
ABG could be used to assess oxygenation; several studies show that NIBP
sufficiently reliable for short procedures, such as endoscopies; RV failure
most directly diagnosed via TEE, but can be inferred from high CVP,
hypotension, and increased pressor requirements; use of TEE, invasive
monitoring such as arterial line for moderate- to high-risk procedures, fluid,
and cardiac output management with a PA catheter should be considered for
patients with LVAD.
Hemodynamic management: Maintain preload with judicious use of fluid and
blood products; discuss with LVAD team for lowest acceptable hematocrit
and transfuse accordingly; manage afterload so as to maintain MAP and
LVAD flow rate close to baseline.
Ventilation: Avoid hypoxia, hypercarbia, and acidosis, which can worsen right
heart function; if positive pressure ventilation, avoid high PEEP, high tidal
volume, watch for high airway pressures, choose technique to achieve 1lung ventilation based on clinical presentation, anticipate if patient may
remain intubated at the end of procedure. If required, vasopressin can be a
good vasopressor choice as it has minimal effect on pulmonary vasculature.
Positioning: Watch for kinks in LVAD driveline while positioning; take care
to avoid any accidental dislodgment or disconnection of any LVAD
component during positioning and repositioning.
Abbreviations: ASA, American Society of Anesthesiologists; ECG,
electrocardiogram; LVAD, left ventricular assist device; MAP, mean arterial
pressure; NIBP, noninvasive blood pressure; PA, pulmonary artery; PEEP,
positive end-expiratory pressure; TEE, transesophageal echocardiography.
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